Bortezomib Terminated Phase 1 / 2 Trials for Malignancies / Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00560352Safety Study of Dasatinib With Bortezomib (VelcadeĀ®) and Dexamethasone for Multiple Myeloma
NCT00590603Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
NCT00609817Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
NCT00891033Panobinostat/Velcade in Multiple Myeloma